Regenerative Medical Technology RMTG Income Statement (2017-2026)

OTC RMTG
$0.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Regenerative Medical Technology Quarterly Income Statement

Periods 35 quarters
Latest Jun 2026

Regenerative Medical Technology reported revenue of $4.02M and net income of -$2.91M for the quarter ended Jun 2026, up 309.1% year over year. This income statement covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
0.17M0.25M0.30M0.30M0.37M0.57M0.79M0.36M0.65M0.62M0.82M0.79M0.99M1.51M1.36M0.98M1.18M1.57M2.64M4.02M
Cost of RevenueCost of Rev
0.09M0.17M0.19M0.15M0.10M0.21M0.25M0.11M0.20M0.18M0.25M0.27M0.24M0.53M0.42M0.40M0.68M0.79M0.87M1.44M
Gross Profit
0.08M0.08M0.11M0.15M0.26M0.36M0.54M0.25M0.45M0.43M0.57M0.53M0.75M0.98M0.94M0.59M0.50M0.78M1.77M2.58M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
0.01M0.03M0.03M0.04M0.04M-0.05M0.03M0.06M0.10M0.07M0.05M0.06M0.06M-0.05M0.03M0.03M0.05M0.07M0.07M0.07M
Selling, General & AdministrativeSG&A
0.05M0.08M0.10M0.13M0.11M0.08M0.18M0.23M0.15M0.20M0.16M0.26M0.26M0.11M0.25M0.21M0.28M0.39M0.48M0.62M
Other Operating ExpensesOther Opex
9.03M0.47M0.52M0.35M0.28M2.78M0.40M0.39M0.28M0.30M0.46M0.42M0.40M0.54M0.54M0.60M0.62M0.62M0.99M1.33M
Operating ExpensesOpex
9.09M0.58M0.65M0.51M0.43M2.82M0.61M0.68M0.53M0.57M0.67M0.74M0.73M0.60M0.81M0.84M0.95M1.09M1.54M2.01M
Operating IncomeOp. Inc
-9.02M-0.50M-0.54M-0.37M-0.16M-2.46M-0.07M-0.43M-0.08M-0.14M-0.11M-0.21M0.02M0.38M0.13M-0.25M-0.45M-0.31M0.23M0.57M
EBIT
-9.02M-0.50M-0.54M-0.37M-0.16M-2.46M-0.07M-0.43M-0.08M-0.14M-0.11M-0.21M0.02M0.38M0.13M-0.25M-0.45M-0.31M0.23M0.57M
Non-operating items
Non Operating Interest Expenses
0.90M1.06M1.14M1.13M1.18M1.66M1.63M1.85M1.86M0.91M1.02M0.90M1.06M3.49M2.01M2.19M2.23M
Other Non Operating IncomeOther Non Op Inc.
-2.49M-1.14M-1.13M-1.18M3.47M0.00M998.00964.001.51M-0.00M-708.00-0.00M885.00-0.00M-0.14M-865.000.92M1.08M-1.24M
Non Operating IncomeNon Op. Inc.
-5.78M-0.12M-1.86M-1.86M-0.91M-1.02M-0.89M-1.19M-3.91M-1.09M-1.11M-3.47M
Net income details
EBT
-9.92M-1.56M-1.68M-1.50M-1.34M-2.46M-0.07M-0.43M-1.73M-1.77M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M-1.67M
Profit After TaxPAT
-9.92M-1.57M-1.68M-1.49M-1.34M-1.06M-1.67M-2.03M-5.86M-0.26M-1.96M-2.08M-0.89M-0.64M-0.76M-1.44M-4.35M-1.39M-0.88M-2.91M
Income from Continuing OperationsIncome (Continuing)
-9.92M-1.56M-1.68M-1.50M-1.34M-2.46M-0.07M-0.43M-1.73M-1.77M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M-1.67M
Income from Discontinued OperationsIncome (Discontinued)
-124.00208.00-434.000.07M
Consolidated Net IncomeConsol Net Inc.
-9.92M-1.56M-1.68M-1.50M-1.35M-2.39M-0.07M-0.43M-1.73M-1.77M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M-1.67M
Income towards Parent CompanyParent Net Inc
-9.92M-1.56M-1.68M-1.50M-1.35M-2.39M-0.07M-0.43M-1.73M-1.77M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M-1.67M
Net Income towards Common StockholdersNet Income
-9.92M-1.56M-1.68M-1.50M-1.35M-2.39M-0.07M-0.43M-1.73M-1.77M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M-1.67M
Additional items
EPS (Basic)
-0.82-0.14-0.14-0.12-0.11-0.20-0.01-0.03-0.14-0.14-0.16-0.17-0.07-0.05-0.06-0.10-0.31-0.18-0.15-0.13
EPS (Diluted)
-0.82-0.14-0.14-0.12-0.11-0.20-0.01-0.03-0.14-0.14-0.16-0.17-0.07-0.05-0.06-0.10-0.31-0.18-0.15-0.13
Shares Outstanding
12.03M11.48M12.09M12.22M12.25M12.22M12.44M12.44M12.44M12.45M12.49M12.49M12.54M12.53M12.54M12.54M12.54M12.63M13.14M13.22M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
12.03M11.48M12.09M12.22M12.25M12.22M12.44M12.44M12.44M12.45M12.49M12.49M12.54M12.53M12.54M12.54M12.54M12.63M13.14M13.22M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
12.03M12.09M12.16M12.25M12.25M12.44M12.44M12.44M14.05M12.49M12.49M12.49M12.54M12.54M12.54M12.54M12.54M13.14M13.14M13.74M
EBITDA
-9.00M-0.47M-0.52M-0.33M-0.12M-2.50M-0.04M-0.37M0.02M-0.06M-0.05M-0.16M0.08M0.33M0.16M-0.22M-0.39M-0.23M0.30M0.63M
Interest ExpensesInt Expense
0.90M1.06M1.14M1.13M1.18M1.66M1.63M1.85M1.86M0.91M1.02M0.90M1.06M3.49M2.01M2.19M2.23M